ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Program Project Guidelines Available

October 27, 1995

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

June 25, 1981

National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials

March 5, 1999

Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts

June 30, 1989

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999